| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5262 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2751 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1649 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1326 | 2021 |
| T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ... Nature medicine 27 (2), 270-278, 2021 | 582 | 2021 |
| Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study PM Short, SIW Lipworth, DHJ Elder, S Schembri, BJ Lipworth Bmj 342, 2011 | 390 | 2011 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ... Nature medicine 27 (2), 279-288, 2021 | 330 | 2021 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 329 | 2018 |
| Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review A Dagens, L Sigfrid, E Cai, S Lipworth, V Cheng, E Harris, P Bannister, ... bmj 369, 2020 | 187 | 2020 |
| The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD PM Short, PA Williamson, DHJ Elder, SIW Lipworth, S Schembri, ... Chest 141 (1), 81-86, 2012 | 133 | 2012 |
| Defining dormancy in mycobacterial disease S Lipworth, RJH Hammond, VO Baron, Y Hu, A Coates, SH Gillespie Tuberculosis 99, 131-142, 2016 | 88 | 2016 |
| Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection B Lipworth, R Chan, S Lipworth, CRW Kuo The Journal of Allergy and Clinical Immunology: In Practice 8 (6), 1798-1801, 2020 | 65 | 2020 |
| SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex S Lipworth, R Jajou, A de Neeling, P Bradley, W van der Hoek, ... Emerging Infectious Diseases, 2019 | 59 | 2019 |
| Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus S Lipworth, N Hough, L Leach, M Morgan, K Jeffery, M Andersson, ... Antimicrobial agents and chemotherapy 63 (1), 10.1128/aac. 01204-18, 2019 | 52* | 2019 |
| Genomic surveillance of Escherichia coli and Klebsiella spp. in hospital sink drains and patients B Constantinides, KK Chau, TP Quan, G Rodger, MI Andersson, K Jeffery, ... Microbial genomics 6 (7), e000391, 2020 | 50* | 2020 |
| Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you? RJH Hammond, VO Baron, K Oravcova, S Lipworth, SH Gillespie Journal of Antimicrobial Chemotherapy 70 (10), 2823-2827, 2015 | 50 | 2015 |
| Comparison of R9. 4.1/Kit10 and R10/Kit12 Oxford Nanopore flowcells and chemistries in bacterial genome reconstruction ND Sanderson, N Kapel, G Rodger, H Webster, S Lipworth, TL Street, ... Microbial genomics 9 (1), 000910, 2023 | 41 | 2023 |
| Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review E Webb, I Rigby, M Michelen, A Dagens, V Cheng, AM Rojek, D Dahmash, ... BMJ global health 7 (8), e009838, 2022 | 41 | 2022 |
| Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK S Lipworth, KD Vihta, K Chau, L Barker, S George, J Kavanagh, T Davies, ... Genome medicine 13, 1-13, 2021 | 41 | 2021 |
| Preparing clinicians for (re-) emerging arbovirus infectious diseases in Europe L Sigfrid, C Reusken, I Eckerle, V Nussenblatt, S Lipworth, J Messina, ... Clinical Microbiology and Infection 24 (3), 229-239, 2018 | 39 | 2018 |
